Skip to Content

Publications Search - Abstract View

Title: A genome-wide scan for breast cancer risk haplotypes among African American women.
Authors: Song C,  Chen GK,  Millikan RC,  Ambrosone CB,  John EM,  Bernstein L,  Zheng W,  Hu JJ,  Ziegler RG,  Nyante S,  Bandera EV,  Ingles SA,  Press MF,  Deming SL,  Rodriguez-Gil JL,  Chanock SJ,  Wan P,  Sheng X,  Pooler LC,  Van Den Berg DJ,  Le Marchand L,  Kolonel LN,  Henderson BE,  Haiman CA,  Stram DO
Journal: PLoS One
Date: 2013
Branches: CGR, EBP, HREB, LTG
PubMed ID: 23468962
PMC ID: PMC3585353
Abstract: Genome-wide association studies (GWAS) simultaneously investigating hundreds of thousands of single nucleotide polymorphisms (SNP) have become a powerful tool in the investigation of new disease susceptibility loci. Haplotypes are sometimes thought to be superior to SNPs and are promising in genetic association analyses. The application of genome-wide haplotype analysis, however, is hindered by the complexity of haplotypes themselves and sophistication in computation. We systematically analyzed the haplotype effects for breast cancer risk among 5,761 African American women (3,016 cases and 2,745 controls) using a sliding window approach on the genome-wide scale. Three regions on chromosomes 1, 4 and 18 exhibited moderate haplotype effects. Furthermore, among 21 breast cancer susceptibility loci previously established in European populations, 10p15 and 14q24 are likely to harbor novel haplotype effects. We also proposed a heuristic of determining the significance level and the effective number of independent tests by the permutation analysis on chromosome 22 data. It suggests that the effective number was approximately half of the total (7,794 out of 15,645), thus the half number could serve as a quick reference to evaluating genome-wide significance if a similar sliding window approach of haplotype analysis is adopted in similar populations using similar genotype density.